A1 Refereed original research article in a scientific journal
Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact
Authors: Timo Carpén, Stina Syrjänen, Lauri Jouhi, Reija Randen‑Brady, Caj Haglund, Antti Mäkitie, Petri S. Mattila, Jaana Hagström
Publisher: SPRINGER
Publication year: 2020
Journal: Cancer Immunology, Immunotherapy
Journal acronym: CANCER IMMUNOL IMMUN
Volume: 69
Issue: 8
First page : 1615
Last page: 1626
Number of pages: 12
ISSN: 0340-7004
eISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-020-02570-3
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/47254761
Background The etiological role of human papillomavirus (HPV) in oropharyngeal squamous cell carcinoma (OPSCC) is confirmed. However, the role of other oncoviruses in OPSCC is unknown.
Materials and methods A total of 158 consecutive OPSCC patients treated with curative intent were included. DNA extracted from tumor sections was used to detect Epstein-Barr virus (EBV), HPV, and the following polyomaviruses: John Cunningham virus (JCV), Simian virus 40 (SV40), and BK virus (BKV) with PCR. In addition, p16 expression was studied by immunohistochemistry, and EBV-encoded small RNA (EBER) transcripts were localized by in situ hybridization. The effect of viral status on overall survival (OS) and disease-free survival (DFS) was analyzed.
Results A total of 94/158 samples (59.5%) were HPV-positive, 29.1% contained BKV DNA, 20.3% EBV DNA, 13.9% JCV DNA, and 0.6% SV40 DNA. EBER was expressed only in stromal lymphocytes adjacent to the tumor and correlated with HPV positivity (p = 0.026). p16 expression associated only with HPV. None of the three polyomaviruses had an impact on survival. Patients with EBER-positive but HPV-negative OPSCC had significantly poorer OS and DFS than those with HPV-positive OPSCC and slightly worse prognosis compared with the patients with EBER-negative and HPV-negative OPSCC.
Conclusion Polyomaviruses are detectable in OPSCC but seem to have no impact on survival, whereas HPV was the strongest viral prognostic factor. EBER expression, as a sign of latent EBV infection, may have prognostic impact among patients with HPV-negative OPSCC. EBER analysis may identify a new subgroup of OPSCCs unrelated to HPV.
Downloadable publication This is an electronic reprint of the original article. |